Elevation Oncology, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Elevation Oncology, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2020 to Q3 2024.
  • Elevation Oncology, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $1.15M, a 36.9% increase year-over-year.
  • Elevation Oncology, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $3.39M, a 13.4% decline year-over-year.
  • Elevation Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.34M, a 4.02% increase from 2022.
  • Elevation Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $3.21M, a 104% increase from 2021.
  • Elevation Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $1.57M, a 2921% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $3.39M $1.15M +$311K +36.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $3.08M $1.05M +$303K +40.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $2.77M $902K -$562K -38.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $3.34M $284K -$575K -66.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-06
Q3 2023 $3.91M $843K -$40K -4.53% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $3.95M $744K -$93K -11.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $4.04M $1.46M +$837K +133% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $3.21M $859K +$170K +24.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-06
Q3 2022 $3.04M $883K +$224K +34% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $2.81M $837K +$679K +430% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $2.13M $627K +$562K +865% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $1.57M $689K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 $659K +$644K +4293% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $158K +$146K +1217% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $65K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q3 2020 $15K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $12K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.